One in three people is at risk for diabetes. So 23andMe set out to develop the first direct-to-consumer genetic test to assess whether its users have a higher likelihood of developing type 2 diabetes, which is the most common form of the disease.
LONDON (Reuters) – A global diabetes epidemic is fuelling record demand for insulin but tens of millions will not get the injections they need unless there is a dramatic improvement in access and affordability, a new study concluded on Wednesday. FILE PHOTO: An employee poses at the insulin production plant of Danish multinational pharmaceutical company… Read More »
Esperion’s experimental treatment for lowering cholesterol is poised to help millions of patients, CEO Tim Mayleben told CNBC on Wednesday.